Linda Palczuk
CIK 1717580 · Chief Operating Officer · last filed 2026-02-12
Linda Palczuk is a Chief Operating Officer who has filed 28 SEC Form 4 insider transactions across 3 companies since 2017. The most recent filing shows the insider disposed of $1.7M of AVDL on Feb 12, 2026. Across all open-market trades the lifetime net is +$319.6K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $4.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.7K
3
28
$319.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Director | 0 | $21.64 | $0 | $201.7K | 23 | 2026-02-12 |
| VRCA | Chief Operating Officer | 850 | $5.49 | $4.7K | $117.9K | 4 | 2019-03-04 |
| OSIRIS THERAPEUTICS, INC. (OSIR) Delisted | President & CEO | — | — | — | $0 | 1 | 2017-09-21 |
Recent Filings
28 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-12 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Disp (D) | −78,905 | -$1.66M | EDGAR |
| 2025-09-15 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Gift (G) | — | $0 | EDGAR |
| 2025-07-31 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Grant (A) | +11,000 | $0 | EDGAR |
| 2025-01-28 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Gift (G) | — | $0 | EDGAR |
| 2025-01-22 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Buy (P) | +5,000 | $39.6K | EDGAR |
| 2024-12-27 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Gift (G) | −3,500 | $0 | EDGAR |
| 2024-12-19 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-12-10 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Buy (P) | +3,000 | $30.6K | EDGAR |
| 2024-09-16 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Gift (G) | — | $0 | EDGAR |
| 2024-08-01 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Grant (A) | +11,000 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.